The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor mutational burden identifies chemorefractory gastric cancer with overall survival advantage after receiving toripalimab, a PD-1 antibody.
 
Rui-hua Xu
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Xiao-Li Wei
No Relationships to Disclose
 
Fenghua Wang
No Relationships to Disclose
 
Nong Xu
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose
 
Guanghai Dai
No Relationships to Disclose
 
Xianglin Yuan
No Relationships to Disclose
 
Ye Chen
No Relationships to Disclose
 
Shujun Yang
No Relationships to Disclose
 
Jianhua Shi
No Relationships to Disclose
 
Xi-Chun Hu
No Relationships to Disclose
 
Xiaoyan Lin
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Ji Feng Feng
No Relationships to Disclose
 
Yi Ba
No Relationships to Disclose
 
Yunpeng Liu
No Relationships to Disclose
 
Hai Wu
Employment - Shanghai Junshi BioSciences
Leadership - Shanghai Junshi BioSciences
Stock and Other Ownership Interests - Shanghai Junshi BioSciences
 
Hui Feng
Employment - Shanghai Junshi BioSciences
Leadership - Shanghai Junshi BioSciences
Stock and Other Ownership Interests - Shanghai Junshi BioSciences
 
Sheng Yao
Employment - Shanghai Junshi BioSciences
Leadership - Shanghai Junshi BioSciences
Stock and Other Ownership Interests - Shanghai Junshi BioSciences